Euformatics is pleased to announce its newest partner in the Middle East , Africa, and Central Asia. Alliance Group Global (AGBL). With this exclusive distributor agreement AGBL will be able to offer validation, data quality management and variant interpretation to its end users. The 3 main focus products are: omnomicsV for NGS test validation omnomicsQ…
ESPOO, Finland, October, 2018. – Finnish bioinformatics company, Euformatics have received 0.7 million Euros from the EU Horizon 2020 programme to participate in GEMMA, a groundbreaking international autism research project aimed at developing individualized care and preventing the onset of Autism Spectrum Disorders (ASD). The company is responsible for providing the genomic data software infrastructure…
The free-of-charge OncoMatic online tool will no longer be available from Horizon. However, the online data QC tool is still available for use directly from Euformatics as the omnomicsQ service. All data that has been uploaded to OncoMatic is available in omnomicsQ. The OncoMatic user login credentials can be used to access omnomicsQ (http://omnomics.com) until…
Location: Milan, Italy 16–18 June 2018 Join Euformatics at ESHG 2018 to learn more about our comprehensive NGS variant interpretation, internal quality management and test validation tools. Come meet us in person at the EMQN booth #440 or arrange a meeting with our team to learn more about NGS quality and validation here.
ESPOO, Finland, November, 2017.– Finnish bioinformatics firm, Euformatics has released an improved version of its CE-marked omnomicsNGS software that incorporates the AMP/ASCO Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer. The AMP/ASCO/CAP guidelines establish a four-tiered system based on clinical evidence from drug labels, guidelines, and peer-reviewed publications for categorizing the…
Location: Salt Lake City, Utah, USA 16 – 18 November 2017 AMP is the leading organization in the field of molecular diagnostics, and this meeting is “the premiere gathering” of molecular professionals. The theme of the meeting this year will be, Where Molecular Leads Medicine to Best Patient Care. Visit Euformatics at the Horizon Discovery…
Location: Boston/Woburn, MA, USA 17 – 19 October 2017 Euformatics CSO, Christophe Roos will present on behalf of Horizon Discovery on Thursday, Oct. 19 at 12:40 on the topic ‘Validation of NGS Workflows for Precision Medicine’ and cover the following: Best practice clinical guidelines for the validation of NGS pipelines in a personalised medicine context…
Euformatics, the experts in high standard NGS bioinformatics tools for genomic data quality and interpretation today announce their partnership with Horizon Discovery and the launch of the jointly developed online companion NGS validation and QC solution, OncoMatic. “We are proud to combine our IT expertise in high-throughput sequencing bioinformatics with Horizon’s newly launched reference material in order to…
Location: Copenhagen, Denmark 27–30 May 2017 Join Euformatics at ESHG 2017 to learn more about our comprehensive NGS variant interpretation, internal quality management and test validation tools. You can arrange a meeting with our team or contact us to learn more about NGS quality and validation here.
Location: Göteborg, Sweden 10–12 May 2017 Our geneticist, Dr. Christophe Roos will be presenting on Thursday 11th May, 9:00 – 9.30 on the topic of NGS data validation, quality management, utilisation. You can arrange a meeting with our team or contact us to learn more about NGS quality here.